Novo Nordisk

Scott Galloway: Why I'm selling my American stocks

My First Million

Pharmaceutical company cited as a potential source of GLP-1 drugs; Scott mentions estimating a macro policy scenario involving a billion doses.

No. 1 Sugar Expert: You've Been Sold A Lie About "Healthy" Food!

The Diary Of A CEO

Dave Ricks, CEO of Eli Lilly | The All-In Interview

All-In Podcast

A competitor in the diabetes and obesity drug market, particularly mentioned in relation to GLP-1 development and insulin pricing.

In conversation with Reid Hoffman & Robert F. Kennedy Jr.

All-In Podcast

Danish pharmaceutical company that produces Ozempic, criticized for lobbying to make Medicare cover its drug and its influence on diabetes treatment recommendations.